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SUMMARY
Laboratory tests in adult outpatients with longer lasting coughs to identify a potential causal
pathogen are rarely performed, and there is no gold standard for these diagnostic tests. While the
diagnostic validity of serological tests for pertussis is well established their potential contribution
for diagnosing adenovirus and influenza virus A and B infections is unclear. A sentinel study into
the population-based incidence of longer lasting coughs in adults was done in Rostock (former
East Germany) and Krefeld (former West Germany). A total of 971 outpatients who consulted
general practitioners or internists were included. Inclusion criteria were coughing for 51 week
and no chronic respiratory diseases. We evaluated the performance of polymerase chain reaction
(PCR) as well as IgG and IgA serology, applying a latent class model for diagnosing infections
with adenovirus, B. pertussis, and influenza virus A and B. The adult outpatients first sought
medical attention when they had been coughing for a median of 3 weeks. In this situation, direct
detection of infectious agents by PCR had a low sensitivity. Modelling showed that additional
serological tests equally improved sensitivity and specificity for diagnosis for adenovirus,
B. pertussis and influenza virus A and B infections. The combination of serology and PCR may
improve the overall performance of diagnostic tests for B. pertussis and also for adenovirus, and
influenza virus A and B infections.
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INTRODUCTION
With the advent of molecular methods in diagnostic
virology, real-time polymerase chain reaction (PCR)
is regarded as the method of choice for diagnosing
viral respiratory diseases such as influenza A and B
and adenovirus infections [1]. In adult outpatients,
however, symptoms may persist for a lengthy period
before medical attention is sought, and consequently,
even if attempted, the sensitivity of direct detection of
viruses may be not sufficiently high. For infections
with Bordetella pertussis in adults, various studies
have demonstrated that the sensitivity of Bordetella
PCR was well below 10% and thus, serology has
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been the mainstay for diagnosing these infections [2].
As no accepted ‘gold standard’ exists for these infec-
tions, latent class analysis (LCA) has been successfully
applied to estimate the sensitivities and specificities of
PCR and serology for pertussis diagnosis [3]. LCA is a
well-documented and statistically valid tool in absence
of a gold standard [3, 4]. Moreover, the characteristics
of this method have been extensively studied in com-
parison with estimates where a gold standard was
available [4].
We used a sentinel study into longer lasting cough
in adults with almost 1000 patients in two German cit-
ies to study the application of the latent class model
for the diagnosis of pertussis and to extend it to the
diagnosis of adenovirus as well as influenza virus A
and B infections in order to evaluate the relative role
of viral serology in this outpatient population.
PATIENTS AND METHODS
Patients were recruited from general practitioners
(GPs) and internists, who were active in general in-
ternal medicine (Allgemeinärztlich tätige Internisten)
(summarized as GPs) in Krefeld (former West
Germany) and Rostock (former East Germany).
Between 2001 and 2004 a total of 971 patients were
included in the study. The study had 21 sentinels in
Rostock and 14 in Krefeld. The 21 sentinels in
Rostock treated 34·2% of all patients in Rostock and
the 14 sentinels in Krefeld treated 19·2% of patients
there. This study was approved by the ethical commit-
tees of the medical boards in Krefeld (Ärztekammer
Nordrhein) and Rostock (Ärztekammer Mecklenburg-
Vorpommern).
Inclusion criteria. Adult patients with a cough of 57
days’ duration were eligible for inclusion. Patients
treated for chronic respiratory diseases such as chronic
obstructive pulmonary disease, and patients partici-
pating in other studies were excluded. Clinical data
about symptomatology, other diseases, contacts, pro-
fessional background, duration of coughing and
days off work were collected by two questionnaires.
The first questionnaire asked about the duration of
coughing before the first visit, for various other symp-
toms, for a history of similar episodes and for a con-
tact anamnesis.
A total of 971 patients were included (455 from
Rostock, 516 from Krefeld). Sixty-seven per cent
were female (n = 650) and 33% were male (n= 221).
The female:male ratio in Rostock was 71:29, and in
Krefeld 65:35 (P > 0·2). The age distribution of all
patients is given in Figure 1.
A total of 934 patients reported the duration of
coughing symptoms before the first visit. For estima-
tion of the mean time of symptoms before seeking
medical attention we assumed that a total of 80
patients (8·5%) reporting symptoms for >3 months
(12 weeks) would suffer from chronic coughing, and
these were excluded from estimating the mean time be-
fore the first visit. Another 14 patients (1·5%) reported
symptoms for <7 days (inclusion criterion) and these
were also excluded from analysis.
Diagnostic procedures. A nasopharyngeal swab, pha-
ryngeal washing and a peripheral blood sample was
taken from all patients at presentation at the sentinels.
Nasopharyngeal swabs were immersed in modified
Amies medium with charcoal. Pharyngeal washings
were sampled into a sterile tube. All samples were
transported at ambient temperature to the central
laboratory (Krefeld).
Laboratory tests. Nasopharyngeal swabs were tested
for Bordetella DNA by real-time PCR targeting
IS481 (B. pertussis), and IS1001 (B. parapertussis)
[5]. Pharyngeal washings were tested for adenovirus
DNA, and influenza viruses A and B RNA by an
in-house real-time PCR. For adenovirus PCR, a 131
nt fragment from the hexon gene of human adeno-
virus type 2, belonging to adenovirus species C, was
amplified using TaqMan primers and probes and the
amplification was performed on a 7500 RT–PCR sys-
tem (ABI Biosystems, USA) [6]. For influenza A virus
a 101 nt fragment from the M gene was amplified. The
reverse primer was degenerated and a specific primer
for the haemagglutinin variant H1sw was added.
The probe was tagged with an amplifier molecule
(ZNA; zipped nucleic acid). For influenza B virus a
89 nt fragment from the M gene was amplified.
Amplification was done either on a 7500 RT–PCR
or StepOne system (ABI Biosystems) [7].
Serum samples were tested for IgG and IgA anti-
bodies to adenovirus, for IgG and IgA antibodies to
influenza virus A and B with a nucleoprotein as the re-
spective antigen by micro-well ELISAs (all Virion
Serion GmbH, Würzburg, Germany). IgG and IgA
antibodies to pertussis toxin (PT) were measured by
an in-house ELISA [8].
Interpretation of serology results. The commercial
ELISAs measured antibodies quantitatively in arbi-
trary unit (AU/ml). The sensitivity of the commercial
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test systems was set to detect no antibodies to influenza
virus A and B in healthy blood donors, irrespective of
their immunization status to influenza virus. For anti-
bodies to adenovirus, 95% of obviously healthy blood
donors had no antibodies detected. Thus, we defined
all detectable antibody levels as possibly indicative of
a recent contact. For IgG anti-PT we followed the
recommendations of the European reference laborator-
ies [9] and5100 IU/ml was regarded as indicative of re-
cent contact. For IgA anti-PT512 IU/ml was regarded
as indicative of recent contact.
Statistical evaluation
We used LCA to assess diagnostic test accuracy [10].
LCA hypothesizes the existence of one or more unob-
served categorical variables to explain the relation-
ships between a set of observed categorical variables.
We treat the latent variable which corresponds to mul-
tiple positive diagnoses as the unobserved true disease
status of the patients [11]. In the medical diagnosis
context, the observed variables are, e.g. test results,
usually dichotomized into a binary classification
(positive and negative).
In the LCA model a posterior probability of the
infections of interest is estimated with a frequentist
expectation-maximization (EM) algorithm proposed
by Qu et al. [12]. For each possible test combination
a response pattern depicting the posterior probability
of being infected was calculated. If the posterior
probability was >0·50, subjects were classified as
infected [3]. We repeated each LCA several times with
different starting values for the EM algorithm in order
to identify a stable pattern as proposed by Beath [13].
Sensitivity and specificity of the individual tests were
estimated from the LCA. The sensitivity is the probabil-
ityof the respective test to identify the subject correctlyas
infected under the condition that the subject is infected.
Specificity on the other hand is the probability of correct-
ly identifying a subject as not infected. Since the true
infection status is unknown the latent class method
constructs a hypothetical standard, and assesses the indi-
vidual test’s performance with respect to this hypoth-
etical standard [13]. The 95% confidence limits were
calculated using bootstrap methods [14].
As a sensitivity analysis we applied Bayesian LCA
with non-informative priors via EM algorithms and
Gibbs sampler [15], a Markov chain Monte Carlo
(MCMC) method. For the Gibbs sampler a sufficient
burn-in was chosen and thinning was used to reduce
autocorrelation between the observed output terms
[16, 17]. An overview of the applied methods is
described in Gentle et al. [18].
All analyses were performed with statistical soft-
ware R 3.1.2 [19] and the add-on packages
randomLCA [20] and BayesLCA [15].
RESULTS
From the 934 patients, who reported the duration of
coughing symptoms, we assumed that 80 had chronic













<20 20–29 30–39 40–49 50–59 60–69 70–79 ≥80



























Fig. 1. Age distribution of study patients.
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for <1week. The remaining 840 patients reported cough-
ing for a mean of 25·8 ± 17·6 days (3·7 weeks) and for a
median of 21 days [95% confidence interval (CI) 7–63
days] before first seeking medical attention. No statistic-
ally significant difference was observed in the duration of
symptoms between Krefeld and Rostock (P> 0·1).
Of the 971 study subjects, 948 patients had three
tests for pertussis and 949 had three tests for adeno-
virus and influenza A and B, respectively.
Pertussis
A positive test result for pertussis was observed in 39
subjects (4·1%) by PT IgG, in 64 subjects (6·8%) by
PT IgA and in 11 subjects (1·2%) by B. pertussis PCR
(Table 1). Based on the LCA model a total of 23 sub-
jects were classified as infected (Supplementary
Table S1). According to this model, 22 (18 + 4) out of
23 (96%) could be detected with the test combination
of PT IgG and PT IgA. Based on the LCA model the
sensitivity for PT IgG was estimated as 1·00 (95% CI
0·99–1·00) followed by PT IgA 0·81 (95% CI 0·00–
1·00) and B. pertussis PCR 0·19 (95% CI 0·04–0·53)
(Table 2). The specificity was high in all tests. The
data presented in Table 2 are based on the frequentist
EM algorithm. A Bayesian EM algorithm and the
Gibbs sampler yielded identical classification of pertus-
sis infection (data not shown).
Adenovirus
A positive test result for adenovirus was observed in
123 subjects (13·0%) by adenovirus IgG, in 176 sub-
jects (18·5%) by adenovirus IgA and in 23 subjects
(2·4%) by adenovirus PCR (Table 1). Based on the
LCA model a total of 176 subjects were classified as
infected (Supplementary Table S2). According to
this model, all infected subjects could be detected by
adenovirus IgA. The highest sensitivity was estimated
as 1·00 (95% CI 0·99–1·00) for adenovirus IgA, 0·81
(95% CI 0·00–1·00) for adenovirus IgG and 0·19
(95% CI 0·04–0·53) for adenovirus PCR (Table 2).
The specificity was high in all tests. The Bayesian
EM algorithm and the Gibbs sampler yielded identi-
cal classification of adenovirus infection as the fre-
quentist EM algorithm (data not shown).
Influenza A
A positive test result for influenza A was observed in
47 subjects (5·0%) by influenza A IgG, in 132 subjects
Table 1. Overall test results for polymerase chain









PT IgG 909 (95·89) 39 (4·11)
PT IgA 884 (93·25) 64 (6·75)
Bp PCR 937 (98·84) 11 (1·16)
Adenovirus
Adeno IgG 826 (87·04) 123 (12·96)
Adeno IgA 773 (81·45) 176 (18·55)
Adeno PCR 926 (97·58) 23 (2·42)
Influenza A
InfA IgG 902 (95·05) 47 (4·95)
InfA IgA 817 (86·09) 132 (13·91)
InfA PCR 938 (98·84) 11 (1·16)
Influenza B
InfB IgG 705 (74·29) 244 (25·71)
InfB IgA 892 (93·99) 57 (6·01)
InfB PCR 941 (99·16) 8 (0·84)
PT IgG, IgG antibodies to pertussis toxin (PT); PT IgA, IgA
antibodies to PT; Bp PCR, PCR for detecting Bordetella
DNA; Adeno IgG, IgG antibodies to adenovirus; Adeno
IgA, IgA antibodies to adenovirus; Adeno PCR, PCR for
detecting adenovirus DNA; InfA IgG, IgG antibodies to
influenza virus A; InfA IgA, IgA antibodies to influenza
virus A; InfA PCR, PCR for detecting influenza virus A
RNA; InfB IgG, IgG antibodies to influenza virus B; InfB
IgA, IgA antibodies to influenza virus B; InfB PCR, PCR
for detecting influenza virus B RNA.
Table 2. Estimated sensitivity and specificity of
indicators of pertussis, adenovirus and influenza
according to latent class analysis
Test Sensitivity Specificity
B. pertussis
PT IgG 1·00 (0·99–1·00) 0·99 (0·67–1·00)
PT IgA 0·81 (0·00–1·00) 0·95 (0·89–0·98)
Bp PCR 0·19 (0·04–0·53) 0·99 (0·93–1·00)
Adenovirus
Adeno IgG 0·39 (0·01–0·93) 0·93 (0·13–1·00)
Adeno IgA 1·00 (0·41–1·00) 1·00 (0·99–1·00)
Adeno PCR 0·05 (0·00–0·43) 0·98 (0·96–0·99)
Influenza A
InfA IgG 0·99 (0·21–1·00) 1·00 (0·99–1·00)
InfA IgA 0·21 (0·00–0·99) 0·86 (0·00–1·00)
InfA PCR 0·02 (0·00–1·00) 0·99 (0·44–1·00)
Influenza B
InfB IgG 1·00 (0·99–1·00) 0·76 (0·04–0·99)
InfB IgA 1·00 (0·98–1·00) 0·96 (0·06–1·00)
InfB PCR 0·10 (0·00–1·00) 0·99 (0·96–1·00)
Values in parentheses are 95% confidence intervals.
For abbreviations see Table 1.
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(13·9%) by influenza A IgA and in 11 subjects (1·2%)
by influenza A PCR (Table 1). Based on the LCA
model a total of 47 subjects were classified as infected,
all detected by influenza A IgG (Supplementary
Table S3). Low sensitivity was estimated with 0·21
(95% CI 0·00–0·99) for influenza A IgA and 0·02
(95% CI 0·00–1·00) for influenza A PCR (Table 2).
Both Bayesian LCA models yielded the same pre-
dicted group membership for influenza A (data not
shown).
Influenza B
For influenza B a positive test result was observed in
244 subjects (25·7%) by influenza B IgG, in 57 subjects
(6·0%) by influenza B IgA and in eight subjects (0·8%)
by influenza B PCR (Table 1). In the estimated LCA
model for influenza B a total of 29 subjects were clas-
sified as infected by both influenza B IgG and
influenza B IgA (Supplementary Table S4). A very
low sensitivity with 0·10 (95% CI 0·00–1·00) was esti-
mated for influenza B PCR (Table 2). Influenza B IgG
had a high false-positive rate resulting in a moderate
specificity. Both Bayesian LCA models yielded the
same predicted group membership for influenza B
(data not shown).
DISCUSSION
In this cohort of adult patients in Germany who were
coughing for 57 days before seeking medical atten-
tion, the combination of serology and PCR seemed
not only to improve the overall performance of diag-
nostic tests for B. pertussis but also for adenovirus,
and influenza virus A and B infections.
For interpretation of our data some points of our
study design are worth discussing: first, our inclusion
criteria selected against detecting influenza-like ill-
nesses, as the clinical definition of influenza would
normally require an acute onset with high fever
and pronounced malaise. In our study setting we
found that patients were coughing for a median of 3
weeks before visiting a physician. Consequently, we
assume that the detection of viral RNA for influenza
virus A and B, as well as viral DNA for adenovirus
may have a similarly low sensitivity as has been docu-
mented in adult pertussis cases for detection of
Bordetella DNA [2, 5]. In this respect, our study
reproduced the assumption made in an earlier study
using LCA [3]. Our pre-analytics, however, may
have additionally disadvantaged the detection of
viral nucleic acids, as we used oropharyngeal washings
that were found to be less sensitive than nasopharyn-
geal samples [21]. In that study, it was observed that in
550 hospitalized patients, viral RNA/DNA could be
detected in 136 oropharyngeal swabs, and also in
184 nasopharyngeal swabs. However, at the time of
our study, our protocol depended on oropharyngeal
washings. Furthermore, the diagnostic gold standard
is also a function of age. Whereas in adults, sensitivity
of PCR is rather low, it can be around 70% in infants
or young children who visit their physician/paediatri-
cian early after the onset of cough [5].
The specificity of the antigens used in diagnostic
serology may be another reason for concern. In per-
tussis serology, recommendations about the use of
specific antigens have been published [9], but many
serological kits still need to evolve and follow the con-
sensus recommendations, which is not always the case.
This is a major problem not only for routine biologic-
al diagnosis but also epidemiological studies. In
influenza serology, and even less so in adenoviral ser-
ology, no consensus about antigens useful in the diag-
nosis of respiratory disease has been achieved. The
commercial ELISA systems employed in this study
used nucleoproteins for influenza A and B serology
and hexon protein for adenovirus serology. For
influenza serology these tests have been successfully
used in diagnostic serology [22] with a good sensitivity
and specificity. For adenovirus respiratory infections
in non-immunocompromised adults, isotype-specific
ELISA systems were only rarely used [23], but dis-
played sufficient sensitivity and specificity.
We deliberately did not confine the analyses to
cases with confirmed coughing between 7 days and 3
months. Instead we chose an ‘intention to diagnose’
approach to be as close as possible to the physicians’
diagnostic perspective. According to the physician,
all patients had met the predefined case definition
and for these patients the potential diagnostic proper-
ties of our test combination needed to be established.
The LCA model used here is a well-documented
and statistically valid tool in the absence of a gold
standard [3, 4] This approach has been used in another
cohort with suspected pertussis [3], but has not previ-
ously been applied to a combined set of tests for per-
tussis, adenovirus, and influenza A and B in a large
population of adult patients with respiratory disease
and cough. A methodological strength of our analysis
is the validation of the frequentist approach by
Bayesian approaches. A methodological limitation
of this approach is that a combination of only three
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tests was applied. The total number of ‘true’ cases
identified might be greater if a further set of diagnostic
tests had been be available for the LCA. Due to the
limited number of tests underlying the analysis, we
could not use the random-effects model proposed by
Qu et al. [12] that integrate local dependence between
tests through a single normally distributed random ef-
fect [24]. This may be a critical issue since the assump-
tion of conditional independence is often violated in
practice [4, 12, 24, 25]. It has been shown that ignoring
conditional independence biases the estimates of diag-
nostic accuracy. Even under study conditions, how-
ever, a combination of more than three tests is very
unusual, and in clinical diagnostic practice diagnostic
tests for outpatients with chronic coughs are rarely if
ever applied. Thus, a recently published clinical guide-
line on acute coughs in adults [26] only mentions per-
tussis when a laboratory diagnosis may be attempted.
We partly estimated wide confidence limits for the
sensitivity or specificity. This could be caused by no
or only a few subjects in some response patterns, lead-
ing to a very flat likelihood. In this case, the estimates
will have a high variance even if the likelihood is iden-
tifiable [27].
The role of acute infections in chronic cough in
adults without underlying lung disease was unknown.
In a population of >900 individuals with clinical signs
of respiratory disease and cough and without positive
PCR, additional cases of B. pertussis, adenovirus, and
influenza virus A and B infections were identified by
serology (Table 1). For all conditions a combination
of IgG and IgA serological testing had the best test
performance while PCR had little overall value in
this setting. Although PCR is generally regarded as
the diagnostic ‘gold standard’, our study shows that
for this patient group the addition of diagnostic viral
serology may be a valuable adjunct for laboratory
diagnosis. Given the constraints of the study, however,
additional work is needed to prospectively define the
optimal use of PCR and diagnostic serology in longer
lasting coughing disease in adults.
APPENDIX. KRESH Sentinel Physicians
Krefeld: Frau und Herr Dr. Rieger, Praxis Dr.
Krausbauer und Frau Dr. Möhrke, Herr Dr. Dotzel,
Herr Dr. Frackenpohl, Praxis Dr. Lüdemann und
Herr Dr. Schultz, Herr Dr. Urban, Herr Dr.
Urlbauer, Herr Dr. Baselt, Herr Dr. Ridderskamp,
Praxis Dr. Hochbruck und Dr. Hermann, Praxis Dr.
Kemmerich und Dr. Thomaßen, Herr Dr. Meißner,
Herr Dr. Seelhoff.
Rostock: Frau Dr. Lusch, Herr Dr. Rothe, Frau Dr.
Krüger, Herr Dr. Th. Hohlbein, Frau Dr. Borchmann,
Frau Dr. Kähler, Frau Dr. Bichowski, Frau Dr.
Lüder, Frau Dr. Glaser, Frau Dr. B. Hohlbein, Frau
Dr. Vilbrandt, Herr Dr. Anft, Frau Dr. Burow, Frau
Dr. Olwig, Frau Dr. Engelhardt, Frau Dr. Lange,
Herr Dr. Langer, Frau Dr. Evert, Frau Dr. Michelsen,
Frau Dr. Frank, Frau Dr. Morcan
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